Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

NEULAND LABS Plunges 10%; BSE HEALTHCARE Index Up 1.3%
Wed, 6 Nov 15:19

NEULAND LABS Plunges 10%; BSE HEALTHCARE Index Up 1.3%Image source: CreativaImages/www.istockphoto.com

NEULAND LABS share price has plunged 10% and is presently trading at Rs 14,250.0.

Meanwhile, the BSE HEALTHCARE index is at 44,480.3 (up 1.3%).

Among the top losers in the BSE HEALTHCARE index today are IPCA Labs (down 0.8%) and Lupin (down 0.6%).

GRANULES INDIA (up 4.5%) and CAPLIN POINT (up 4.4%) are among the top gainers today.

Over the last one year, NEULAND LABS has moved up from Rs 4,054.8 to Rs 14,250.0, registering a gain of Rs 10,195.3 (up 251.4%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,089.2 to 44,480.3, registering a gain of 58.4% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were Jubilant Pharmova (up 209.6%), Glenmark Pharma (up 133.9%) and SUVEN PHARMACEUTICALS (up 132.4%).

Dear Reader: If You Invest in Midcap Stocks, this is for You

What About the Benchmark Indices?

The BSE Sensex is at 80,337.3 (up 1.1%).

The top gainers among the BSE Sensex today are TCS (up 4.2%) and Infosys (up 3.8%). The most traded stocks in the BSE Sensex are ITC and Tata Steel.

In the meantime, NSE Nifty is at 24,471.7 (up 1.1%). Bharat Electronics and Adani Enterprises are among the top gainers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 64,958.7 to 80,337.3, registering a gain of 15,378.6 points (up 23.7%).

NEULAND LABS Financial Update...

NEULAND LABS net profit grew 58.2% YoY to Rs 979 million for the quarter ended June 2024, compared to a profit of Rs 619 million a year ago. Net sales rose 21.1% to Rs 4,396 million during the period as against Rs 3,630 million in April-June 2023.

For the year ended March 2024, NEULAND LABS reported 83.5% increase in net profit to Rs 3,001 million compared to net profit of Rs 1,635 million during FY23. Revenue of the company grew 30.8% to Rs 15,586 million during FY24.

The current Price to earnings ratio of NEULAND LABS, based on rolling 12 month earnings, stands at 54.4.


Equitymaster requests your view! Post a comment on "NEULAND LABS Plunges 10%; BSE HEALTHCARE Index Up 1.3%". Click here!